Preclinical Medical Cannabis Research

Raphael Pharmaceutical Issues Letter to Shareholders

The letter highlights the company’s exclusive relationship with Rambam Health Care Campus, differentiated cannabinoid-based technology platform, promising lead product candidate for rheumatoid arthritis, recently commenced clinical study, broader pipeline opportunities, and overall mission and vision.